SCOPUS 정보 검색 플랫폼

Volumn 33, Issue 4, 2001, Pages 989-993

A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C

(12) Mangia, Alessandra a Minerva, Nicola a Annese, Mauro b Leandro, Gioacchino a Villani, Maria Rosaria a Santoro, Rosanna a Carretta, Vito c Bacca, Donato f Giangaspero, Antonio e Bisceglia, Michele a Ventrella, Francesco d Dell'erba G b

a Ospedale Canosa (Italy)

b NONE (Italy)

c NONE (Italy)

d NONE (Italy)

e UNIVERSITY OF BARI MEDICAL SCHOOL (Italy)

f NONE (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 17744398404 PISSN: 02709139 EISSN: None Source Type: Journal
DOI: 10.1053/jhep.2001.23537 Document Type: Article

Times cited : (60)

References (27)

1
- 0032585237
- Randomized trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niederau, C.⁴ Minuk, G.⁵ Ideo, G.⁶ Bain, V.⁷

2
- 0032501714
- Randomized, double-blind placebo controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C
- (1998) Lancet , vol.351 , pp. 83-87
- Reichard, O.¹ Norkrans, G.² Fryden, A.³ Braconier, J.H.⁴ Sonnerborg, A.⁵ Weiland, O.⁶

3
- 0032547938
- Interferon alfa 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutchinson, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶ Goodman, Z.D.⁷

4
- 0035071635
- Efficacy of 5 MU of interferon therapy in combination with ribavirin for naïve patients with chronic HCV hepatitis: A randomized controlled trial
- (2000) J Hepatol , vol.36 , pp. 441-446
- Mangia, A.¹ Villani, M.R.² Minerva, N.³ Leandro, G.⁴ Cela, M.⁵ Carretta, V.⁶

5
- 0000427158
- EASL International Consensus Conference on Hepatitis C Consensus Statement
- (1999) J Hepatol , vol.31 , pp. 1-7

6
- 0017924141
- On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride
- (1978) J Gen Virol , vol.38 , pp. 97-110
- Skehel, J.¹ Hay, A.² Armstrong, J.³

7
- 0018929513
- Inhibition of dengue virus replication by amantadine hydrochloride
- (1980) Antimicrob Agents Chemother , vol.18 , pp. 125-129
- Koff, W.¹ Elm, J.² Halstead, S.³

8
- 0030822539
- Treatment of chronic hepatitis C with amantadine
- (1997) Dig Dis Sci , vol.42 , pp. 1681-1687
- Smith, J.¹

9
- 0032449441
- Amantadine hydrochloride decreases serum ALT activity without effects on serum HCV RNA in chronic hepatitis C patients
- (1998) Ital J Gastroenterol Hepatol , vol.30 , pp. 611-613
- Tabone, M.¹ Ercole, E.² Zaffino, C.³ Sallio, B.⁴ Pera, A.⁵ Bonino, F.⁶

10
- 0001558135
- Amantadine monotherapy in patients with chronic hepatitis C
- (1996) Gastroenterology , vol.114 , pp. 1316A
- Olmeda, A.¹ Khalili, M.² Perrillo, R.P.³

11
- 0032898676
- The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C
- (1999) Semin Liver Dis , vol.19 , pp. 95-102
- Younossi, Z.M.¹ Perrillo, R.P.²

12
- 0001075825
- Amantadine in HCV chronic infection: A 6 months follow up study
- (1998) J Hepatol , vol.28 , pp. 105A
- Mangia, A.¹ Facciorusso, D.² Lezzi, G.³ Villani, M.R.⁴ Gentile, R.⁵ Rizzetto, M.⁶ Andriulli, A.⁷

13
- 0000560623
- Amantadine monotherapy of chronic hepatitis C patients infected with genotype 1b
- (1998) Hepatology , vol.28 , pp. 373A
- Senturk, H.¹ Mert, A.² Akdogan, M.³ Tabak, F.⁴ Basaran, G.⁵ Ozbay, G.⁶ Badur, S.⁷

14
- 85003505684
- Amantadine monotherapy is ineffective in liver transplant recipients with recurrent HCV-related chronic hepatitis
- (1999) J Hepatol , vol.30 , pp. 139A
- Angelico, M.¹ Orlando, G.² Di Paolo, D.³ Palmieri, G.⁴ Anselmo, A.⁵ Strati, F.⁶ Pisani, F.⁷

15
- 0001304797
- Amantadine therapy for recurrent hepatitis C after liver transplantation
- (1998) Hepatology , vol.28 , pp. 347A
- Lynch, P.J.¹ Peters, M.G.² Lowell, J.A.³ Shenoy, S.⁴ Howard, T.K.⁵ Caldwell, C.A.⁶

16
- 0001188134
- Interferon α2b and ribavirin vs interferon α2b and amantadine for chronic hepatitis C (non-responder): A multi-center, randomized double-blind trial
- (1998) Hepatology , vol.28 , pp. 284A
- Younossi, Z.M.¹ Mullen, K.² Zakko, W.³ Brandt, E.⁴ Hodnicks, S.⁵ Easley, K.⁶ Barnes, D.⁷

17
- 0034097487
- Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C
- (2000) Am J Gastroenterol , vol.95 , pp. 1284-1289
- Kalili, M.¹ Denham, C.² Perrillo, R.³

18
- 0033839967
- Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C
- (2000) Hepatology , vol.32 , pp. 630-634
- Brillanti, S.¹ Levantesi, F.² Masi, L.³ Foli, M.⁴ Bolondi, L.⁵

19
- 85003622749
- Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: A UK multicentre study
- (2000) J Hepatol , vol.32 , pp. 110A
- Caronia, S.¹ Bassendine, P.² Mills, P.³ Naumoy, N.⁴ Fox, J.⁵ Lowes, R.⁶ Barry, I.⁷

20
- 85003576181
- Interferon + amantadine combination therapy in naïve patients with chronic active hepatitis C: Preliminary results
- (2000) Dig Liver Dis , vol.32 , pp. A116
- Tabone, M.¹ Pera, A.²

21
- 0033807659
- Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C
- (2000) Hepatology , vol.32 , pp. 835-841
- Zeuzem, S.¹ Teuber, G.² Naumann, U.³ Berg, T.⁴ Readle, J.⁵ Hartmann, S.⁶ Hopf, U.⁷

22
- 0028000832
- Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma
- (1994) J Med Virol , vol.43 , pp. 125-128
- Mangia, A.¹ Vallari, D.² DiBisceglie, A.M.³

23
- 0026578617
- The pathology of hepatitis C
- (1992) Hepatology , vol.15 , pp. 567-571
- Scheuer, P.J.¹ Ashrafzadeh, P.² Scherlock, S.³ Brown, D.⁴ Dusheiko, G.M.⁵

24
- 85003721603
- Combination of interferon alfa-2a and amantadine does not improve the efficacy of interferon therapy in patients with chronic hepatitis C
- (1999) Hepatology , vol.30 , pp. 833A
- Sieng-Sing, Y.¹ Tien-Chien, T.² Chi-Hwa, W.³

25
- 85003678938
- Amantadine and rimantadine have no specific inhibitory, activity against hepatitis C IRES, protease, helicase, NTPase, and polymerase
- (1999) Hepatology , vol.28 , pp. 370A
- Jubin, R.¹ Murray, M.G.² Howe, A.Y.M.³ Butkiewicz, N.⁴ Hong, Z.⁵ Lau, J.Y.N.⁶

26
- 0032903035
- In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-Infected patients
- (1999) Antiviral Res , vol.42 , pp. 59-70
- Martin, J.¹ Navas, S.² Fernandez, M.³ Rico, M.⁴ Pardo, M.⁵ Quiroga, J.A.⁶ Carreno, V.⁷

27
- 0023807899
- Clinical pharmacokinetics of amantadine hydrocloride
- (1988) Clin Pharmacol , vol.12 , pp. 35-51
- Aoki, F.Y.¹ Sitar, D.S.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.